<DOC>
	<DOCNO>NCT01309009</DOCNO>
	<brief_summary>This phase IIa study design multi-centre , single country , randomise , double-blind , placebo control study three parallel group , aim evaluate efficacy safety Nepadutant give two oral dos daily seven day comparison placebo treatment infantile colic .</brief_summary>
	<brief_title>Preliminary Efficacy Safety Study Oral Nepadutant Infant With Colic Not Responding Conventional Treatment</brief_title>
	<detailed_description>Infant colic functional gastrointestinal disorder affect 30 % infant population ; primarily characterise excessive inconsolable cry start without apparent cause last several hour per day . Current non pharmacological intervention ( e.g . message , restriction maternal diet breast-feeding infant ) pharmacological treatment ( simethicone , antimuscarinic drug ) largely unsatisfactory . In animal model , Nepadutant reverse exaggerate intestinal motility sensitivity , induced different stimulus , without produce inhibitory effect function baseline , suggest Nepadutant could therapeutic effect interference physiological gastrointestinal transit . This phase IIa study design evaluate efficacy Nepadutant paediatric oral solution give daily two dos comparison placebo . The experimental clinical phase encompass follow period : - Screening period ( study medication ) do 7 4 day prior randomisation - Treatment period , last seven day daily administration - Post treatment period , last seven day A safety follow-up visit perform approximately 1 month first administer dose .</detailed_description>
	<mesh_term>Colic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>MEN 11420</mesh_term>
	<criteria>Healthy infant diagnosis infant colic accord follow modified Wessel criterion `` paroxysm irritability , fuss cry start stop without obvious cause &gt; 3h/day , &gt; 3 days/week one week '' Age â‰¥ 6 week &lt; 4 month No adequate response conventional pharmacological nonpharmacological treatment alternative infant colic Infants exclusively breastfed . Normal growth Willingness refrain use antimuscarinic drug , simethicone , dimethicone antiacid study period Clinical evidence allergy disease may cause cry and/or fussiness may interfere absorption clearance drug . Suspect gastroesophageal reflux disease ( GERD ) Formula feed mixed fed infant .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Infantile Colic</keyword>
	<keyword>Tachykinin antagonist</keyword>
	<keyword>Nepadutant</keyword>
</DOC>